C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/44 (2006.01) A61K 31/472 (2006.01) A61P 25/18 (2006.01) A61P 25/22 (2006.01) A61P 25/28 (2006.01)
Patent
CA 2382326
The invention provides a pharmaceutical composition and kit for treating certain neurologic and psychiatric disorders in mammals, including humans, comprising a selective PDE10 inhibitor. In particular, the invention relates to treatment of mood, movement, and anxiety disorders; psychosis; drug, for example alcohol, addiction; and disorders having as a symptom deficient cognition. The invention furthermore provides the use of papaverine as a selective inhibitor of PDE10.
Lebel Lorraine Ann
Menniti Frank Samuel
Schmidt Christopher Joseph
Pfizer Products Inc.
Smart & Biggar
LandOfFree
Therapeutic use of selective pde10 inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic use of selective pde10 inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic use of selective pde10 inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1507574